The American College of Veterinary Internal Medicine (ACVIM) is excited to announce a new endorsement partnership with IDEXX Laboratories, Inc., of complimentary resident-focused educational...
Dysregulated T lymphocyte response is thought to play a key role in chronic intestinal inflammation (CIE). This prospective case-control study aimed to evaluate the presence of changes in peripheral...
Excessive inbreeding increases the probability of uncovering homozygous recessive genotypes and has been associated with an increased risk of retained placenta and lower semen quality. No genomic...
Non-steroidal anti-inflammatory drugs (NSAIDs) are often used as part of a multi-modal approach to manage chronic pain in cats, but minimizing adverse effects is necessary.
To determine the frequency of abnormal findings on digital rectal examination (DRE) performed during physical examinations at a tertiary referral veterinary hospital, to establish what abnormal...
The Belle Époque was a historical period characterized by economic growth, technological and scientific advancements, and significant improvements in living conditions, particularly for the...
This case report describes a cat with severe erythrocytosis (Hct, 80%), which after initial treatment with hydroxyurea has gone into remission for over 3 years.
The purpose of this study was to assess sedation, emesis and cardiovascular effects of dexmedetomidine alone or combined with acepromazine in healthy cats.
Cardiac disease is diagnosed with increased frequency in pet guinea pigs (Cavia porcellus) prompting the need for an improved understanding of disease-related sequelae. There are currently no reports...
Increased serum cortisol (COR) concentrations may induce glucocorticoid resistance by down-regulation of glucocorticoid receptor (GCR), resulting in decreased chemotherapy efficacy in dogs with...
The Human Animal Bond Research Institute (HABRI) and MetLife Pet Insurance Solutions LLC (“MetLife Pet”), one of the world’s leading financial services companies, today announced a...
Phibro Animal Health Corporation (Nasdaq: PAHC) today announced the successful completion of the acquisition of the medicated feed additive product portfolio and certain water-soluble products from...
_02.jpg)
